Quarterly Returns (%)Nektar Therapeutics
| Years | Q1 | Q2 | Q3 | Q4 | Annual |
|---|---|---|---|---|---|
| 1994 | 0 | -26.7 | 77.5 | -5.3 | 0 |
| 1995 | -16 | 3.1 | 50 | -17 | 5.6 |
| 1996 | 56.2 | 21.4 | -30.4 | 17.4 | 54.9 |
| 1997 | 26.5 | 29.5 | 26.7 | -17.1 | 72 |
| 1998 | 4.3 | -8.7 | 13.1 | 17.9 | 26.9 |
| 1999 | -17.8 | -12.2 | 27.5 | 40.1 | 29 |
| 2000 | 75.1 | 36.2 | 11.1 | -0.8 | 137.3 |
| 2001 | -57.7 | 11.2 | -44.4 | 41.3 | -63.3 |
| 2002 | -43.1 | -9.8 | -35 | 60.6 | -56.4 |
| 2003 | -21.8 | 45.1 | 39.6 | 6.3 | 68.4 |
| 2004 | 58.1 | -7.3 | -27.5 | 39.8 | 48.7 |
| 2005 | -31.1 | 20.7 | 0.7 | -2.9 | -18.7 |
| 2006 | 23.8 | -10 | -21.4 | 6.4 | -7.6 |
| 2007 | -14.1 | -27.1 | -8.1 | -25.3 | -55.9 |
| 2008 | 3.4 | -51.7 | 7.2 | 54.9 | -17.1 |
| 2009 | -3.1 | 20.2 | 50.3 | -4.3 | 67.6 |
| 2010 | 63.2 | -20.5 | 22.1 | -13 | 37.9 |
| 2011 | -26.3 | -23.2 | -33.3 | 15.5 | -56.4 |
| 2012 | 41.4 | 3.7 | 30.4 | -30.6 | 32.3 |
| 2013 | 48.5 | 7 | -12.6 | 8.6 | 53.2 |
| 2014 | 6.8 | 5.8 | -5.9 | 28.4 | 36.6 |
| 2015 | -29 | 13.7 | -12.4 | 53.7 | 8.7 |
| 2016 | -18.4 | 3.5 | 20.7 | -28.6 | -27.2 |
| 2017 | 91.3 | -16.7 | 22.8 | 141.1 | 386.7 |
| 2018 | 77.9 | -50.6 | 24.8 | -42 | -45 |
| 2019 | 2.2 | 3.6 | -49.7 | 17.1 | -35.2 |
| 2020 | -5 | 4 | 8 | 2.5 | -20.2 |
| 2021 | 17.9 | -14.4 | 5 | -25.1 | -20.5 |
| 2022 | -59.8 | -30 | -15.8 | -29.4 | -83.3 |
| 2023 | -68.9 | -18.2 | 3.7 | -0.9 | -75 |
| 2024 | 63.7 | 26.9 | -6.3 | -32.9 | 65.1 |
| 2025 | 20 | 0 | 0 | 20 |